- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Out-of-pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured men.
September 3, 2024
Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer.
September 2, 2024
Genomic landscape of early-stage prostate adenocarcinoma in Mexican patients: an exploratory study.
September 2, 2024
Immune effects of α and β radionuclides in metastatic prostate cancer.
September 2, 2024
Diffusion MRI in prostate cancer with ultra-strong whole-body gradients.
September 2, 2024
68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG.
September 2, 2024
Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer.
August 30, 2024
The 340B Program and High-Risk Prescribing of Oral Targeted Therapies for Advanced Prostate Cancer.
August 30, 2024
Prostate Cancer Early Detection in the European Union and UK.
August 30, 2024
Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer.
August 30, 2024
PARP inhibitors alone or in combination for prostate cancer.
August 30, 2024
Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer.
August 29, 2024
5-α Reductase Inhibitors and Prostate Cancer Mortality.
August 29, 2024
Mortality from prostate cancer in the years 2007-2021 in North Rhine-Westphalia, Germany.
August 29, 2024
Appropriateness of Imaging for Low-Risk Prostate Cancer-Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC).
August 29, 2024